TORONTO STOCK EXCHANGE · MSLE
-3.72% · -$0.3600 · Vol 19.8K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Satellos Bioscience Inc

Satellos Bioscience Inc

Biotechnology
$9.32
Card
Relationship Map

Follow $MSLE

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MSLE by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
MSLE
Satellos Bioscience Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

57/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MSLE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MSLE catalysts
About Satellos Bioscience Inc
Biotechnology
Listed since
2021
Employees
21
Country
CA

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.72
Day high
$9.75
Day low
$9.31
Previous close
$9.68
52W high
$13.01
-28.36% from high
52W low
$5.59
50% of range
Market cap
$197.7M
EPS
$-1.9820
Beta
1.51
Shares out
21.2M
Volume
19.8K
0.78× rel vol
Avg volume
25.5K
VWAP
$9.47
Price history computed in-house
1W
-4.41%
1M
-6.89%
3M
+60.97%
SMA 50 $9.53 · below
SMA 200 Not reported · Not reported
52W position 50%

MSLE overview

Veridion Score
57
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MSLE.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MSLE Form 4 filings
Public disclosures

Congress activity in MSLE

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MSLE in the cached public ledger.

Federal contracts

MSLE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MSLE in this window.
Lobbying spend

MSLE lobbying filings, year to date.

Registered lobbying filings matched to Satellos Bioscience Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MSLE in this window.
Loading news for MSLE
Analyst ratings
Sovereign unlock shows live analyst consensus for MSLE.
Options
Sovereign unlock shows live options positioning for MSLE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.